Fujian Aonong Biological Technology Grouporp (SHSE:603363) Accounts Payable & Accrued Expense : ¥4,817 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Fujian Aonong Biological Technology Grouporp Accounts Payable & Accrued Expense?

Fujian Aonong Biological Technology Grouporp's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥5,271 Mil) to Dec. 2023 (¥5,277 Mil) but then declined from Dec. 2023 (¥5,277 Mil) to Mar. 2024 (¥4,817 Mil).

Fujian Aonong Biological Technology Grouporp's annual accounts payable & accrued expense increased from Dec. 2021 (¥5,079 Mil) to Dec. 2022 (¥5,422 Mil) but then declined from Dec. 2022 (¥5,422 Mil) to Dec. 2023 (¥5,277 Mil).

Fujian Aonong Biological Technology Grouporp Accounts Payable & Accrued Expense Historical Data

The historical data trend for Fujian Aonong Biological Technology Grouporp's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Aonong Biological Technology Grouporp Accounts Payable & Accrued Expense Chart

Fujian Aonong Biological Technology Grouporp Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,771.84

2,954.40

5,078.64

5,421.74

5,277.46

Fujian Aonong Biological Technology Grouporp Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5,563.02	5,142.41	5,270.98	5,277.46	4,816.94

Fujian Aonong Biological Technology Grouporp Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Fujian Aonong Biological Technology Group Incorp Ltd (SHSE:603363) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Guanyinshan Operation Center, 12th Floor, Building 10, Siming District, Fujian Province, Xiamen, CHN, 361008

Website

http://www.aonong.com.cn

Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.

Executives

Wu You Lin	Directors, senior managers
Huang Hua Dong	Director
Wen Qing Qi	Supervisors
Huang Zu Yao	Director
Lai Jun	senior management
Ye Jun Biao	Director
Yang Jing Quan	senior management
Ding Neng Shui	Director
Luo Zuo Ming	senior management
Hong Yuan Xiang	senior management
Guo Si Hu	senior management
Wu Jun	Director
Huang Ze Sen	senior management
Hou Hao Feng	senior management
Li Hai Feng	senior management

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Headlines

No Headlines